After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Aclaris Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Aclaris Therapeutics Inc is $175.41M. A total of 0.55 million shares were traded on the day, compared to an average of 923.88K shares.
In the most recent transaction, Mehra Anand bought 666,666 shares of ACRS for 2.25 per share on Nov 19 ’24. After the transaction, the Director now owns 710,030 company shares. In a previous transaction on Aug 05 ’24, Leonard Braden Michael bought 206,025 shares at 1.24 per share. ACRS shares that 10% Owner owns now total 14,250,000.
Among the insiders who bought shares, Leonard Braden Michael acquired of 167,544 shares on Aug 02 ’24 at a per-share price of $1.29. This resulted in the 10% Owner holding 14,043,975 shares of ACRS after the transaction. In another insider transaction, Leonard Braden Michael bought 173,730 shares at $1.30 per share on Jul 30 ’24. Company shares held by the 10% Owner now total 13,776,421.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ACRS has a high of $5.17 and a low of $1.05.
As of this writing, ACRS has an earnings estimate of -$0.14 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.12 per share and a lower estimate of -$0.16.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ACRS’s latest balance sheet shows that the firm has $191.41M in Cash & Short Term Investments as of fiscal 2021. There were $693.00k in debt and $22.93M in liabilities at the time. Its Book Value Per Share was $1.33, while its Total Shareholder’s Equity was $197.34M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ACRS is Buy with a score of 4.75.
